Mallory-Denk bodies are associated with outcomes and histologic features in patients with chronic hepatitis C.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Clinical Gastroenterology and Hepatology

• Publication date

  2011-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.cgh.2011.07.006PMID 21782771PMCID PMC3400531
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gender dimorphic formation of Mallory‐Denk bodies and the role of xenobiotic metabolism and oxidative stress

  2010cited by this paper
• Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C.

  2010cited by this paper
• Toward unraveling the complexity of simple epithelial keratins in human disease.

  2009cited by this paper
• Keratin variants are overrepresented in primary biliary cirrhosis and associate with disease severity

  2009cited by this paper
• Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial.

  2009cited by this paper
• Influence of ethnicity on histological differences in non-alcoholic fatty liver disease.

  2009cited by this paper
• Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.

  2009cited by this paper
• The Vote of Acute Medical Inpatients

  2009cited by this paper
• Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon.

  2008cited by this paper
• The genetic background modulates susceptibility to mouse liver Mallory‐Denk body formation and liver injury

  2008cited by this paper
• From Mallory to Mallory-Denk bodies: what, how and why?

  2007cited by this paper
• Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: A prospective study

  2007cited by this paper
• Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT‐C trial

  2006cited by this paper
• Keratin variants associate with progression of fibrosis during chronic hepatitis C infection

  2006cited by this paper
• Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: Results of the HALT‐C cohort

  2005cited by this paper
• Keratins as susceptibility genes for end-stage liver disease.

  2005cited by this paper
• Obesity and Non-Alcoholic Fatty Liver Disease in Chronic Hepatitis C

  2004cited by this paper
• Pathologic features associated with fibrosis in nonalcoholic fatty liver disease.

  2004cited by this paper
• Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders.

  2004cited by this paper
• Obesity and non-alcoholic fatty liver disease

  2004cited by this paper
• Nonalcoholic Steatohepatitis—A Long-Term Follow-Up Study: Comparison with Alcoholic Hepatitis in Ambulatory and Hospitalized Patients

  2003cited by this paper
• Alcoholic and nonalcoholic steatohepatitis.

  2002cited by this paper
• Keratin 8 mutations in patients with cryptogenic liver disease.

  2001cited by this paper
• Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

  1999cited by this paper
• Chronic hepatitis: morphology and nomenclature.

  1994cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985cited by this paper

• Mallory-Denk bodies and hepatocellular senescence: a causal relationship?

  2024cites this paper
• Calpain-mediated proteolysis of vimentin filaments is augmented in Giant Axonal Neuropathy (GAN) fibroblasts exposed to hypotonic stress

  2022cites this paper
• Calpain-mediated proteolysis of vimentin filaments is augmented in giant axonal neuropathy fibroblasts exposed to hypotonic stress

  2022cites this paper
• Correlation of hepatitis C virus-mediated endoplasmic reticulum stress with autophagic flux impairment and hepatocarcinogenesis

  2021cites this paper
• Part 1: Disease of the Heart and Liver

  2020cites this paper
• A combination extract of kaffir lime, galangal, and lemongrass maintains blood lipid profiles, hepatocytes, and liver mitochondria in rats with nonalcoholic steatohepatitis.

  2020cites this paper
• Diverse Functions of Autophagy in Liver Physiology and Liver Diseases

  2019cites this paper
• Animal models of NAFLD from the pathologist's point of view.

  2019cites this paper
• Trehalose activates autophagy and decreases proteasome inhibitor‐induced endoplasmic reticulum stress and oxidative stress‐mediated cytotoxicity in hepatocytes

  2018cites this paper
• Pathology of chronic hepatitis B and chronic hepatitis C

  2017cites this paper
• Mouse genetic background contributes to hepatocyte susceptibility to Fas-mediated apoptosis

  2016cites this paper
• Alleviation mechanisms against hepatocyte oxidative stress in patients with chronic hepatic disorders

  2015cites this paper
• Roles of keratins in intestinal health and disease

  2015cites this paper
• Processes to manage analyses and publications in a phase III multicenter randomized clinical trial

  2014cites this paper
• New therapeutic strategy for hepatocellular carcinoma by molecular targeting agents via inhibition of cellular stress defense mechanisms.

  2014cites this paper
• High‐fat diet triggers Mallory‐Denk body formation through misfolding and crosslinking of excess keratin 8

  2014cites this paper
• Diagnosis of alcoholic liver disease.

  2014cites this paper
• CD73 (ecto‐5′‐nucleotidase) hepatocyte levels differ across mouse strains and contribute to mallory‐denk body formation

  2013cites this paper
• Broad spectrum of hepatocyte inclusions in humans, animals, and experimental models.

  2013cites this paper
• Fluorescent thiophene-based ligands for detection and characterization of disease-associated protein aggregates

  2013cites this paper
• The Role of Inherited Keratin Variants in Liver Disease Development

  2013cites this paper
• The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis.

  2012cites this paper
• Keratins: markers and modulators of liver disease

  2012cites this paper
• Oxidative stress, Nrf2 and keratin up‐regulation associate with Mallory‐Denk body formation in mouse erythropoietic protoporphyria

  2012cites this paper
• Keratin 8 phosphorylation regulates its transamidation and hepatocyte Mallory‐Denk body formation

  2012cites this paper
• Energy determinants GAPDH and NDPK act as genetic modifiers for hepatocyte inclusion formation

  2011cites this paper